New RGD analogue inhibits human platelet adhesion and aggregation and eliminates platelet deposition on canine vascular grafts

Keyphrases

• Canine 100%
• Human Platelets 100%
• Platelet Aggregation 100%
• Platelet Deposition 100%
• Platelet Adhesion 100%
• Vascular Graft 100%
• Concentration-dependent 75%
• Guanidino 75%
• Fibrinogen 75%
• Adenosine Diphosphate 50%
• ED50 50%
• Platelets 50%
• Normal Saline 50%
• Saline Injection 50%
• Glycoprotein IIb-IIIa 50%
• Therapeutic Intervention 25%
• Glycine 25%
• Occupancy 25%
• Thrombosis 25%
• Clinical Setting 25%
• Thrombin 25%
• Femoral Artery 25%
• Prosthetic Grafts 25%
• Fibronectin 25%
• Arginine 25%
• Novel Class 25%
• Aggregation-induced 25%
• Histologic Examination 25%
• Amino Acid Sequence 25%
• Arterial Grafts 25%
• Sepharose 25%
• Polytetrafluoroethylene 25%
• Paired T-test 25%
• Glycoprotein IIb/IIIa Inhibitors 25%
• Platelet Function 25%
• Complete Elimination 25%
• Fibrinogen Binding 25%
• Induced Aggregation 25%
• Final Common Pathway 25%
• Aspartic 25%
• Platelet Thrombus 25%
• Transformed Data 25%
• Drug-treated 25%
• Glycoprotein IIb/IIIa Receptor 25%
• Aggregometry 25%
• Human Platelet Aggregation 25%
• Indium(III) 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Fibrinogen Receptor 100%
• Fibrinogen 100%
• Receptor 50%
• Adenosine Diphosphate 50%
• Table Salt 50%
• Sepharose 25%
• Arginine 25%
• Thromboembolism 25%
• Amino Acid 25%
• Elimination 25%
• Thrombin 25%
• Thrombosis 25%
• Thrombus 25%
• Politef 25%
• Fibronectin 25%
• Indium 25%

Biochemistry, Genetics and Molecular Biology

• Thrombocyte Aggregation 100%
• Thrombocyte Adhesion 100%
• Platelet 100%
• Glycoprotein IIb/IIIa 66%
• Fibrinogen 66%
• Secretion (Process) 33%
• Adenosine Diphosphate 33%
• ED50 33%
• Peptide Sequence 16%
• Thrombocyte Function 16%
• Fibronectin 16%
• Thrombin 16%
• Arginine 16%